Cited by 903Cardiovascular Function and Risk FactorsCardiac Fibrosis and RemodelingCardiomyopathy and Myosin Studies

The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.

Molecular mechanisms of diabetic cardiomyopathy

Open access

Bugger, Heiko, Abel, E. Dale·2014·Diabetologia

DOI 10.1007/s00125-014-3171-6PMC PMC3969857

Open this paper in CoChat — free account Open PDF

Abstract

In recent years, diabetes mellitus has become an epidemic and now represents one of the most prevalent disorders. Cardiovascular complications are the major cause of mortality and morbidity in diabetic patients. While ischaemic events dominate the cardiac complications of diabetes, it is widely recognised that the risk for developing heart failure is also increased in the absence of overt myocardial ischaemia and hypertension or is accelerated in the presence of these comorbidities. These diabetes-associated changes in myocardial structure and function have been called diabetic cardiomyopathy. Numerous molecular mechanisms have been proposed to contribute to the development of diabetic cardiomyopathy following analysis of various animal models of type 1 or type 2 diabetes and in genetically modified mouse models. The steady increase in reports presenting novel mechanistic data on this subject expands the list of potential underlying mechanisms. The current review provides an update on molecular alterations that may contribute to the structural and functional alterations in the diabetic heart.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-014-3171-6

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

MicroRNA miR-133 Represses HERG K+ Channel Expression Contributing to QT Prolongation in Diabetic Hearts
Xiao, J., Luo, X., Lin, H., Zhang, Y., Lu, Y., Wang, N., Zhang, Y., Yang, B., & Wang, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700015200 · Cited by 233
Retracted
Retracted: Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up‐regulation contribute to the onset of diabetic cardiomyopathy
Ma, H., Li, S., Xu, P., Babcock, S. A., Dolence, E. K., Brownlee, M., Li, J., & Ren, J. T. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00547.x · Cited by 154
Retracted
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Development by Self-Digestion
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
The Framingham Study
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,965
Identification of hundreds of conserved and nonconserved human microRNAs
Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., et al. (2005) · Nature Genetics · doi:10.1038/ng1590 · Cited by 1,841
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,835
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520

Show all 153 references

Sorted by citations

Items 301–400 of 903

SIRT1 Activation by Equisetum arvense L. (Horsetail) Modulates Insulin Sensitivity in Streptozotocin Induced Diabetic Rats
Hegedűs, C., Muresan, M. E., Badale, A., Bombicz, M., Varga, B., Szilágyi, A., Sinka, D., Bácskay, I., Popoviciu, M. S., Magyar, I., et al. (2020) · Molecules · doi:10.3390/molecules25112541 · Cited by 35
SGLT1 Inhibition Attenuates Apoptosis in Diabetic Cardiomyopathy via the JNK and p38 Pathway
Lin, N., Lin, H., Yang, Q., Lu, W., Sun, Z., Sun, S., Meng, L., Chi, J., & Guo, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598353 · Cited by 31
Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy
Ke, X., Lin, Z.-R., Ye, Z., Leng, M., Chen, B., Jiang, C., Jiang, X., & Li, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.679655 · Cited by 33
Metabolic Tracing Using Stable Isotope-Labeled Substrates and Mass Spectrometry in the Perfused Mouse Heart
Ruiz, M., Gélinas, R., Vaillant, F., Lauzier, B., & Rosiers, C. D. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2015.06.026 · Cited by 31
Matrine alleviates AGEs- induced cardiac dysfunctions by attenuating calcium overload via reducing ryanodine receptor 2 activity
Wang, J., Tang, Z., Zhang, Y., Qiu, C., Zhu, L., Zhao, N., & Liu, Z. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.010 · Cited by 31
The role of circadian clock-controlled mitochondrial dynamics in diabetic cardiomyopathy
Jin, Z., Ji, Y., Su, W., Zhou, L., Wu, X., Gao, L., Guo, J., Liu, Y., Zhang, Y., Wen, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1142512 · Cited by 34
New therapeutic directions in type II diabetes and its complications: mitochondrial dynamics
Wang, S., Zhao, H., Lin, S., Lv, Y., Lin, Y. N., Liu, Y., Peng, R., & Jin, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1230168 · Cited by 33
Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart
Myers, R. B., Fomovsky, G. M., Lee, S., Tan, M., Wang, B. F., Patwari, P., & Yoshioka, J. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00051.2016 · Cited by 30
A Crude 1-DNJ Extract from Home Made Bombyx Batryticatus Inhibits Diabetic Cardiomyopathy-Associated Fibrosis in db/db Mice and Reduces Protein N-Glycosylation Levels
Zhao, Q., Jia, T., Cao, Q. C., Tian, F., & Ying, W. T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061699 · Cited by 28
Predictors of Exercise Capacity in Patients with Hypertrophic Obstructive Cardiomyopathy
Smith, J. R., Medina‐Inojosa, J. R., Layrisse, V., Ommen, S. R., & Olson, T. P. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110447 · Cited by 30
Blockage of ROS and MAPKs-mediated inflammation via restoring SIRT1 by a new compound LF10 prevents type 1 diabetic cardiomyopathy
Luo, W., Jin, Y., Wu, G., Zhu, W., Qian, Y., Zhang, Y., Li, J., Zhu, A., & Liang, G. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.03.005 · Cited by 32
Long non-coding RNA KCNQ1OT1 increases the expression of PDCD4 by targeting miR-181a-5p, contributing to cardiomyocyte apoptosis in diabetic cardiomyopathy
Zhao, S., Ye, Y.-X., Xu, J., He, Y., Zhang, D.-W., Xia, Z., & Wang, S. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01713-x · Cited by 30
Knowledge domain and emerging trends in diabetic cardiomyopathy: A scientometric review based on CiteSpace analysis
Tao, S., Yang, D., Zhang, L., Yu, L., Wang, Z., Li, L., Zhang, J., Yao, R., Huang, L. S., & Shao, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.891428 · Cited by 30
Iron accumulation and lipid peroxidation: implication of ferroptosis in diabetic cardiomyopathy
Yan, X., Xie, Y., Liu, H., Huang, M., Yang, Z., Dong-qing, A., & Jiang, G. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01135-5 · Cited by 34
Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial
Verma, S., Mazer, C. D., Bhatt, D. L., Raj, S. R., Yan, A. T.-K., Verma, A., Ferrannini, E., Simons, G., Lee, J., Zinman, B., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1959 · Cited by 29
Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies
Ramachandra, C. J. A., Chua, J., Cong, S., Ja, K. P. M. M., SHIM, W. S. N., Wu, J. C., & Hausenloy, D. J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa125 · Cited by 29
Impact of inflammation and anti-inflammatory modalities on diabetic cardiomyopathy healing: From fundamental research to therapy
Zhang, X., Han, X.-W., Jiang, Y., Wang, Y., He, X.-L., Liu, D., Huang, J., Liu, H.-H., Ye, T., Li, S.-J., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110747 · Cited by 29
Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms.
Khan, S., Ahirwar, K., & Jena, G. (2016) · Epigenomics · doi:10.2217/epi-2016-0034 · Cited by 25
High-intensity interval training (HIIT) effectively enhances heart function via miR-195 dependent cardiomyopathy reduction in high-fat high-fructose diet-induced diabetic rats
Khakdan, S., Delfan, M., Meymeh, M. H., Kazerouni, F., Ghaedi, H., Shanaki, M., Kalaki-Jouybari, F., Gorgani‐Firuzjaee, S., & Rahimipour, A. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1511599 · Cited by 29
Interleukin-1β polarization in M1 macrophage mediates myocardial fibrosis in diabetes
Guo, W., Yang, C., Zou, J., Yu, T., Li, M., He, R., Chen, K., Hell, R. C. R., Gross, E. R., Zou, X., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111858 · Cited by 31
MK2 Deletion in Mice Prevents Diabetes-Induced Perturbations in Lipid Metabolism and Cardiac Dysfunction
Ruiz, M., Coderre, L., Lachance, D., Houde, V., Martel, C., Legault, J. T., Gillis, M., Bouchard, B., Daneault, C., Carpentier, A. C., et al. (2015) · Diabetes · doi:10.2337/db15-0238 · Cited by 27
Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism
Ruiz, M., Coderre, L., Allen, B. G., & Rosiers, C. D. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.015 · Cited by 28
Opening of mitoKATP improves cardiac function and inhibits apoptosis via the AKT-Foxo1 signaling pathway in diabetic cardiomyopathy
Duan, P., Wang, J., Yang, L., Wei, S., Su, F., Zhang, S., Duan, Y., Wang, L., & Zhu, Q. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3832 · Cited by 28
Liraglutide alleviates cardiac fibrosis through inhibiting P4hα-1 expression in STZ-induced diabetic cardiomyopathy
Zhao, T., Chen, H., Xu, F., Wang, J., Liu, Y., Xing, X., Guo, L., Zhang, M., & Lu, Q. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy177 · Cited by 29
An adiponectin-S1P axis protects against lipid induced insulin resistance and cardiomyocyte cell death via reduction of oxidative stress
Botta, A. M., Liu, Y., Wannaiampikul, S., Tungtrongchitr, R., Dadson, K., Park, T., & Sweeney, G. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0342-y · Cited by 28
Effects of oral antidiabetic drugs and glucagon-like peptide-1 receptor agonists on left ventricular diastolic function in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis
Ida, S., Kaneko, R., Imataka, K., Ôkubo, K., Shirakura, Y., Azuma, K., Fujiwara, R., Takahashi, H., & Murata, K. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09936-w · Cited by 28
Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell
Khan, S. M., Ahmad, S. S., & Kamal, M. A. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200731174724 · Cited by 28
Diabetes and Cardiovascular Complications: The Epidemics Continue
López‐Díez, R., Egaña-Gorroño, L., Senatus, L. M., Shekhtman, A. G., Ramasamy, R., & Schmidt, A. M. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01504-4 · Cited by 30
MIAT, a potent CVD-promoting lncRNA
Yang, C., Zhang, Y., & Yang, B. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04046-8 · Cited by 28
The multifaceted role of cytochrome P450-Derived arachidonic acid metabolites in diabetes and diabetic cardiomyopathy
Isse, F. A., El-Sherbeni, A. A., & El‐Kadi, A. O. S. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2051045 · Cited by 28
Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress
Bugga, P., Mohammed, S. A., Alam, M. J., Katare, P. B., Meghwani, H., Maulik, S. K., Arava, S. K., & Banerjee, S. K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120862 · Cited by 31
Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?
Belli, M., Barone, L., Bellia, A., Sergi, D., Lecis, D., Prandi, F. R., Milite, M., Galluccio, C., Muscoli, S., Romeo, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314598 · Cited by 29
Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling
Pan, J., Guleria, R. S., Zhu, S., & Baker, K. M. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3020566 · Cited by 29
Application of a Novel Curcumin Analog in the Management of Diabetic Cardiomyopathy
Ren, J. T., & Sowers, J. R. (2014) · Diabetes · doi:10.2337/db14-0863 · Cited by 28
Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism
Sassoon, D., Goodwill, A. G., Noblet, J. N., Conteh, A. M., Herring, B. P., McClintick, J. N., Tune, J. D., & Mather, K. J. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0563-4 · Cited by 28
Knockdown of long noncoding RNA GAS5 protects human cardiomyocyte-like AC16 cells against high glucose-induced inflammation by inhibiting miR-21-5p-mediated TLR4/NF-κB signaling
Zhao, J., Лю, Б., & Li, C. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01795-z · Cited by 28
Pathophysiology of atherosclerosis: Association of risk factors and treatment strategies using plant‐based bioactive compounds
Sharif, H., Akash, M. S. H., Rehman, K., Irshad, K., & Imran, I. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13449 · Cited by 30
Therapeutic potential of GLP-1 receptor agonists in diabetes and cardiovascular disease: mechanisms and clinical implications
Zhang, X., Cao, C., Zheng, F., Liu, C., & Tian, X. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-025-07670-9 · Cited by 27
Metabolic Coordination Structures Contribute to Diabetic Myocardial Dysfunction
Wu, T., Huang, T., Ren, H., Shen, C., Jiang, Q., Fu, X., Liu, S.-Y., Xie, C., Lin, X., Wan, J., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.326044 · Cited by 27
Taohuajing reduces oxidative stress and inflammation in diabetic cardiomyopathy through the sirtuin 1/nucleotide-binding oligomerization domain-like receptor protein 3 pathway
Yao, R., Cao, Y., Wang, C., Xu, L. L., Zhang, X., Deng, Y., Li, F., & Wang, S. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03218-0 · Cited by 27
Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases
Luo, M.-Y., Su, J.-H., Gong, S.-X., Liang, N., Huang, W., Chen, W., Wang, A., & Tian, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.733908 · Cited by 27
Miocardiopatía diabética
Lorenzo-Almorós, A., Cepeda-Rodrigo, J. M., & Lorenzo, Ó. (2020) · Revista Clínica Española · doi:10.1016/j.rce.2019.10.013 · Cited by 31
MicroRNA-193-5p modulates angiogenesis through IGF2 in type 2 diabetic cardiomyopathy
Fan, Y., Shang, Y., Li, B., Dai, S., Wu, W., Cheng, L., & Wang, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.108 · Cited by 27
Inhibition of miR‑186‑5p contributes to high glucose‑induced injury in AC16 cardiomyocytes
Jiang, J., Mo, H., Liu, C., Wu, B., Wu, Z., Li, X., Teng, L., He, S., Li, S., You, Q., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5445 · Cited by 27
Essential role for EGFR tyrosine kinase and ER stress in myocardial infarction in type 2 diabetes
Mali, V., Haddox, S., Hornersmith, C., Matrougui, K., & Belmadani, S. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-2097-5 · Cited by 26
Astrocyte elevated gene‐1 induces autophagy in diabetic cardiomyopathy through upregulation of KLF4
Zhao, L., Zhang, Q., Liang, J., Li, J., Tan, X., & Tang, N. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28249 · Cited by 26
Ginsenoside RG1 ‐induced mesenchymal stem cells alleviate diabetic cardiomyopathy through secreting exosomal circNOTCH1 to promote macrophage M2 polarization
Zhen, J., Bai, J., Liu, J., Men, H., & Yu, H. (2023) · Phytotherapy Research · doi:10.1002/ptr.8018 · Cited by 26
Dual-edged role of SIRT1 in energy metabolism and cardiovascular disease
Zhou, R., Barnes, K., Gibson, S., & Fillmore, N. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00001.2024 · Cited by 29
Gaseous signalling molecule SO2 via Hippo-MST pathway to improve myocardial fibrosis of diabetic rats
Liu, M., Liu, S., Tan, W., Tang, F., Long, J., Li, Z., Liang, B., Chu, C., & Yang, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7714 · Cited by 26
CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart
Belanger, K. K., Nutter, C. A., Li, J., Tasnim, S., Liu, P., Yu, P., & Kuyumcu‐Martinez, M. N. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.126 · Cited by 25
Echocardiographic study of myocardial work in patients with type 2 diabetes mellitus
Liao, L., Shi, B., Ding, Z., Chen, L., Dong, F., Li, J., Zhong, Y. L., & Xu, J. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02482-3 · Cited by 26
Pathological Roles of Oxidative Stress in Cardiac Microvascular Injury
Hou, J. W., Yuan, Y., Chen, P., Lu, K., Tang, Z., Liu, Q., Xu, W., Zheng, D., Xiong, S., & Pei, H. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101399 · Cited by 27
The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus
Puig-Jové, C., Julve, J., Castelblanco, E., Julián, M. T., Amigó, N., Andersen, H. U., Ahluwalia, T. S., Rossing, P. R., Mauricio, D., Jensen, M. T., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01652-z · Cited by 26
The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice
Yan, M., Liu, S., Zeng, W., Guo, Q., Yu, M., Shao, X., Su, L., Liu, Z., Zhang, Y., Wang, L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114919 · Cited by 26
Type 1 Diabetes and Risk of Heart Failure: A Systematic Review and Meta-analysis
Haji, M., Erqou, S., Fonarow, G., & Tcheugui, J. E. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110805 · Cited by 23
ATP releasing channels and the ameliorative effects of high intensity interval training on diabetic heart: a multifaceted analysis
Joukar, S., Rajizadeh, M. A., Bejeshk, M. A., Alavi, S. S., Bagheri, F., Rami, M., & Khoramipour, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-57818-0 · Cited by 26
CircRNAs in diabetic cardiomyopathy
Wan, H., Zhao, S., Zeng, Q., Tan, Y., Zhang, C., Liu, L., & Qu, S. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.03.001 · Cited by 27
Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats
Alaeddine, L. M., Harb, F., Hamza, M. A., Dia, B., Mogharbil, N., Azar, N. S., Noureldein, M. H., Khoury, M. E., Sabra, R., & Eid, A. A. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.010 · Cited by 26
Myricetin alleviates diabetic cardiomyopathy by regulating gut microbiota and their metabolites
Zhu, J., Bao, Z., Hu, Z., Wu, S., Tian, C., Zhou, Y., Ding, Z., & Tan, X. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00268-4 · Cited by 28
ZIP7 contributes to the pathogenesis of diabetic cardiomyopathy by suppressing mitophagy in mouse hearts
Yang, N., Zhang, R., Zhang, H., Yu, Y., & Xu, Z. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02499-2 · Cited by 25
A comprehensive review on diabetic cardiomyopathy (DCM): histological spectrum, diagnosis, pathogenesis, and management with conventional treatments and natural compounds
Abdullah, A. R., Seliem, M. A., Khidr, E. G., Sobhy, A. M., El‐Shiekh, R. A., Hafeez, M. S. A. E., & El-Husseiny, A. A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03980-9 · Cited by 32
Lower sarcoplasmic reticulum Ca2+ threshold for triggering afterdepolarizations in diabetic rat hearts
Popescu, I. R., Yin, G., Velmurugan, S., Erickson, J. R., Despa, F., & Despa, S. I. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.11.001 · Cited by 25
Therapeutic Potential of VEGF-B in Coronary Heart Disease and Heart Failure: Dream or Vision?
Mallick, R., & Ylä‐Herttuala, S. (2022) · Cells · doi:10.3390/cells11244134 · Cited by 25
What is the impact of ferroptosis on diabetic cardiomyopathy: a systematic review
Lou, X., Zhang, Y., Guo, J., Gao, L., Ding, Y., Zhuo, X., Lei, Q., Bian, J., Lei, R., Gong, W., et al. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10336-z · Cited by 25
RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation
Hao, J., Zhou, J., Hu, S., Zhang, P., Wu, H., Yang, J., Zhao, B., Liu, H., Lin, H., Chi, J., et al. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00467.2023 · Cited by 26
Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy
Liu, B., Wei, Y., He, J., Feng, B., Chen, Y., Guo, R., Griffin, M. D., Hynes, S. O., Shen, S., Liu, Y., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03715-2 · Cited by 25
Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications
Mangialardi, G., & Madeddu, P. R. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0730-x · Cited by 26
The protective effects of grape seed procyanidin B2 against asporin mediates glycated low‐density lipoprotein induced‐cardiomyocyte apoptosis and fibrosis
Li, X., Yu, F., Li, B., Fu, C., Yu, X., Xu, M., Cheng, M., & Gao, H. (2019) · Cell Biology International · doi:10.1002/cbin.11229 · Cited by 25
Intracellular O-linked glycosylation directly regulates cardiomyocyte L-type Ca2+ channel activity and excitation–contraction coupling
Ednie, A. R., & Bennett, E. S. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-00820-0 · Cited by 24
Cardiac Glucolipotoxicity and Cardiovascular Outcomes
Cerf, M. E. (2018) · Medicina · doi:10.3390/medicina54050070 · Cited by 25
Pregnancy-associated cardiac dysfunction and the regulatory role of microRNAs
Aryan, L., Medzikovic, L., Umar, S., & Eghbali, M. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00292-w · Cited by 25
Functional resilience of C57BL/6J mouse heart to dietary fat overload
Tadinada, S. M., Weatherford, E. T., Collins, G. V., Bhardwaj, G., Cochran, J. D., Kutschke, W. J., Zimmerman, K., Bosko, A., O'Neill, B. T., Weiss, R. M., et al. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00419.2021 · Cited by 26
Self-citation
New insights into the role of melatonin in diabetic cardiomyopathy
Huang, K., Luo, X., Zhong, Y., Deng, L., & Feng, J. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.904 · Cited by 24
RETRACTED ARTICLE: HMGCS2 silencing attenuates high glucose-induced in vitro diabetic cardiomyopathy by increasing cell viability, and inhibiting apoptosis, inflammation, and oxidative stress
Chen, D., Ruan, X., Liu, Y., & He, Y. (2022) · Bioengineered · doi:10.1080/21655979.2022.2063222 · Cited by 24
Retracted
Diabetes-induced chronic heart failure is due to defects in calcium transporting and regulatory contractile proteins: cellular and molecular evidence
Rupee, S., Rupee, K., Singh, R. B., Hanoman, C., Ismail, A. M. A., Smail, M. M. A., & Singh, J. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10271-5 · Cited by 24
Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments
Zhi, F., Zhang, Q., Liu, L., Chang, X., & Xu, H. (2023) · Cell Stress and Chaperones · doi:10.1007/s12192-023-01361-w · Cited by 24
Comprehensive metabolic modeling of multiple13C-isotopomer data sets to study metabolism in perfused working hearts
Crown, S. B., Kelleher, J. K., Rouf, R., Muoio, D. M., & Antoniewicz, M. R. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00428.2016 · Cited by 24
Endostatin: A Promising Biomarker in the Cardiovascular Continuum?
Ruge, T., Carlsson, A. C., Larsson, A. O., & Ärnlöv, J. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0025 · Cited by 23
Theaflavin 3,3′‐digallate reverses the downregulation of connexin 43 and autophagy induced by high glucose via AMPK activation in cardiomyocytes
Shen, Z., Chen, Q., Jin, T., Wang, M., Ying, H., Lu, J., Wang, M., Zhang, W., Qiu, F., Jin, C., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28432 · Cited by 24
Rg1 protects H9C2 cells from high glucose‐/palmitate‐induced injury via activation of AKT/GSK‐3β/Nrf2 pathway
Yu, H., Zhen, J., Yang, Y., Du, J., Leng, J., & Tong, Q. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15486 · Cited by 24
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies
Rizza, V., Tondi, L., Patti, A. M., Cecchi, D., Lombardi, M., Perone, F., Ambrosetti, M., Rizzo, M., Cianflone, D., & Maranta, F. (2024) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2024.200338 · Cited by 29
Metabolites-mediated posttranslational modifications in cardiac metabolic remodeling: Implications for disease pathology and therapeutic potential
Guo, L., Du, Y., Li, H., He, T., Yao, L., Yang, G., & Yang, X. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156144 · Cited by 25
The effect of a preparation of minerals, vitamins and trace elements on the cardiac gene expression pattern in male diabetic rats
Sárközy, M., Szűcs, G., Pipicz, M., Zvara, Á., Éder, K., Fekete, V., Szűcs, C., Bárkányi, J., Csonka, C., Puskás, L. G., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0248-6 · Cited by 23
Downregulation of Profilin-1 Expression Attenuates Cardiomyocytes Hypertrophy and Apoptosis Induced by Advanced Glycation End Products in H9c2 Cells
Yang, D., Wang, Y., Jiang, M., Deng, X., Pei, Z., Li, F., Xia, K., Zhu, L., Yang, T., & Chen, M. (2017) · BioMed Research International · doi:10.1155/2017/9716087 · Cited by 23
Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysis
Han, B. G., Lee, J. Y., Kim, M. R., Shin, H., Kim, J. S., Yang, J. W., & Kim, J. Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235640 · Cited by 24
Rutin alleviates cardiomyocyte injury induced by high glucose through inhibiting apoptosis and endoplasmic reticulum stress
Wang, J., Wang, R., Li, J., & Yao, Z. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10376 · Cited by 23
Costunolide alleviates hyperglycaemia‐induced diabetic cardiomyopathy via inhibiting inflammatory responses and oxidative stress
Jin, B. R., Chen, Y., Wang, J., Chen, Y., Zhang, M., Huang, J., & Wang, Y. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17686 · Cited by 25
CircMAP3K5 promotes cardiomyocyte apoptosis in diabetic cardiomyopathy by regulating miR ‐22‐3p/ DAPK2 Axis
Shen, M., Wu, Y., Li, L., Zhang, L., Liu, G., & Wang, R. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13471 · Cited by 23
Gasdermin D-Mediated Pyroptosis in Diabetic Cardiomyopathy: Molecular Mechanisms and Pharmacological Implications
Liu, Z., Chen, Y., Yu, M., Yan, M., & Liang, H. (2023) · Molecules · doi:10.3390/molecules28237813 · Cited by 26
Long noncoding RNA s: A new player in the prevention and treatment of diabetic cardiomyopathy?
Ma, C., Luo, H., Liu, B., Li, F., Tschöpe, C., & Fa, X. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3056 · Cited by 22
The Exosome: a New Player in Diabetic Cardiomyopathy
Tao, L., Shi, J. Y., Yang, X., Yang, L., & Hua, F. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9825-x · Cited by 24
Left atrial dysfunction and stiffness in pediatric and adult patients with Type 1 diabetes mellitus assessed with speckle tracking echocardiography
Ifuku, M., Takahashi, K., Hosono, Y., Iso, T., Ishikawa, A., Haruna, H., Takubo, N., Komiya, K., Kurita, M., Ikeda, F., et al. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13141 · Cited by 23
Simultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathy
Malek, V., Sharma, N., & Gaikwad, A. B. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.05.008 · Cited by 22
Mitochondrial and Sarcoplasmic Reticulum Interconnection in Cardiac Arrhythmia
Salazar‐Ramírez, F., Ramos‐Mondragón, R., & García‐Rivas, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.623381 · Cited by 23
miR-30a-5p inhibits the proliferation and collagen formation of cardiac fibroblasts in diabetic cardiomyopathy
Yang, X.-X., & Zhao, Z.-Y. (2022) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0280 · Cited by 24
Δ9-Tetrahydrocannabinol Prevents Cardiovascular Dysfunction in STZ-Diabetic Wistar-Kyoto Rats
Vella, R. K., Jackson, D. J., & Fenning, A. S. (2017) · BioMed Research International · doi:10.1155/2017/7974149 · Cited by 22
Sex Differences in Cardiac Mitochondria in the New Zealand Obese Mouse
John, C., Grune, J., Ott, C., Nowotny, K., Deubel, S., Kühne, A., Schubert, C., Kintscher, U., Regitz‐Zagrosek, V., & Grune, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00732 · Cited by 22
Molecular Connection Between Diabetes and Dementia
Chen, Y., Yu, Q., & Gong, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_6 · Cited by 24
Impact of Diabetes on Mortality and Rehospitalization in Acute Heart Failure Patients Stratified by Ejection Fraction
Al‐Jarallah, M., Rajan, R., Al-Zakwani, I. S., Dashti, R., Bulbanat, B., Ridha, M., Sulaiman, K., Alsheikh-Ali, A. A. A., Panduranga, P., AlHabib, K. F., et al. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12538 · Cited by 22
Retinoid X receptor agonists attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes through LKB1-dependent anti-fibrosis effects
Chai, D., Lin, X., Zheng, Q., Xu, C., Xie, H. B., Ruan, Q., Lin, J., Liu, J., & Zeng, J.-Z. (2020) · Clinical Science · doi:10.1042/cs20190985 · Cited by 22

Authors: Bugger, H., & Abel, E. D.
Affiliations: University of Freiburg (DE)
University of Iowa (US)
Corresponding author: Abel, E. Dale
ORCID: Bugger, Heiko
Abel, E. Dale
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2014-01-30
Volume: 57
Issue: 4
Pages: 660-671
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-014-3171-6
PMC: PMC3969857
OpenAlex: W2006499762
Cited by: 903
References: 153
Citations by year: 2026: 51 · 2025: 76 · 2024: 75 · 2023: 79 · 2022: 95 · 2021: 103 · 2020: 100 · 2019: 66 · 2018: 84 · 2017: 62 · 2016: 54 · 2015: 43 · 2014: 14
FWCI: 9.29
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL108379, U01HL087947)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK092065)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords: diabetic cardiomyopathy, diabetes mellitus, heart failure, myocardial structure and function, type 1 diabetes, type 2 diabetes, animal models of diabetes, genetically engineered mouse models, cardiovascular complications of diabetes
MeSH terms: Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Humans, Diabetic Cardiomyopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mechanisms of diabetic cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks